Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tecogen (TGEN) Cash & Equivalents (2016 - 2025)

Tecogen (TGEN) has disclosed Cash & Equivalents for 15 consecutive years, with $15.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 1089.64% year-over-year to $15.3 million, compared with a TTM value of $15.3 million through Sep 2025, up 1089.64%, and an annual FY2024 reading of $5.4 million, up 5665.95% over the prior year.
  • Cash & Equivalents was $15.3 million for Q3 2025 at Tecogen, up from $1.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $15.3 million in Q3 2025 and bottomed at $93744.0 in Q4 2022.
  • Average Cash & Equivalents over 5 years is $3.1 million, with a median of $2.8 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents crashed 97.41% in 2022, then skyrocketed 5665.95% in 2024.
  • Year by year, Cash & Equivalents stood at $3.6 million in 2021, then plummeted by 97.41% to $93744.0 in 2022, then changed by 0.0% to $93744.0 in 2023, then surged by 5665.95% to $5.4 million in 2024, then skyrocketed by 182.21% to $15.3 million in 2025.
  • Business Quant data shows Cash & Equivalents for TGEN at $15.3 million in Q3 2025, $1.6 million in Q2 2025, and $4.1 million in Q1 2025.